{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:07:29Z","timestamp":1720609649783},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1157\/13091243","type":"journal-article","created":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T10:47:34Z","timestamp":1153392454000},"page":"24-29","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S5","title":["Manejo del paciente neutrop\u00e9nico con fiebre"],"prefix":"10.1016","volume":"23","author":[{"given":"Isidro","family":"Jarque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Salavert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13091243_bib1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/383048","article-title":"Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens","volume":"39","author":"Ramphal","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091243_bib2","first-page":"75","article-title":"Gu\u00eda cl\u00ednica para la evaluaci\u00f3n y el tratamiento del paciente neutrop\u00e9nico con fiebre","volume":"14","author":"Garc\u00eda Rodr\u00edguez","year":"2001","journal-title":"Rev Esp Quimioter"},{"key":"10.1157\/13091243_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1157\/13091243_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00277-003-0764-4","volume":"82","author":"Link","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1157\/13091243_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pizzo","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1157\/13091243_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer: a multicenter randomized trial","volume":"120","author":"De Pauw","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1157\/13091243_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13091243_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/322646","article-title":"A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia","volume":"33","author":"Del Favero","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091243_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1185\/030079905X43631","article-title":"Imipenem\/cilastatin versus piperacillin\/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study","volume":"21","author":"Sanz","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1157\/13091243_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1473-3099(02)00241-4","article-title":"Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis","volume":"2","author":"Furno","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1157\/13091243_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Betalactam monotherapy versus betalactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"key":"10.1157\/13091243_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/cncr.11613","article-title":"Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime","volume":"98","author":"Raad","year":"2003","journal-title":"Cancer"},{"key":"10.1157\/13091243_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/00365540410017590","article-title":"A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies","volume":"36","author":"Cherif","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1157\/13091243_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/dkf087","article-title":"Cefepime plus amikacin versus piperacillin- tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial","volume":"50","author":"Sanz","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13091243_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000077807","article-title":"Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation","volume":"50","author":"D\u2019Antonio","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1157\/13091243_bib16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1086\/376637","article-title":"Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy","volume":"37","author":"Cometta","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091243_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jac\/45.6.843","article-title":"A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy","volume":"45","author":"Erjavec","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13091243_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(05)70164-X","article-title":"Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials","volume":"5","author":"Vardakas","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1157\/13091243_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jac\/dki028","article-title":"Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Paul","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13091243_bib20","first-page":"343","article-title":"Tratamiento de las infecciones relacionadas con cat\u00e9teres venosos de larga duraci\u00f3n","volume":"16","year":"2003","journal-title":"Rev Esp Quimioter"},{"issue":"Suppl 1","key":"10.1157\/13091243_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/383057","article-title":"Initial empirical antimicrobial therapy: duration and subsequent modifications","volume":"39","author":"Tamura","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1157\/13091243_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/383052","article-title":"Empirical antifungal therapy in treating febrile neutropenic patients","volume":"39","author":"Wingard","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091243_bib23","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMe048203","article-title":"Antifungal therapy in patients with fever and neutropeniamore rational and less empirical?","volume":"351","author":"Klastersky","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1157\/13091243_bib24","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1157\/13091243_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005339","article-title":"Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction","volume":"3","author":"Stanworth","year":"2005","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05752307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05752307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T05:09:56Z","timestamp":1555736996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X05752307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":25,"alternative-id":["S0213005X05752307"],"URL":"https:\/\/doi.org\/10.1157\/13091243","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}